NEW YORK (GenomeWeb News) – Epigenomics said that it has reached a financing agreement with YA Global Master SPV for up to €5 million ($6.7 million).

Under the terms of the agreement, YA Global will purchase over two years convertible notes with a total nominal amount of €5 million at a purchase price of 95 percent of the nominal amount. Epigenomics may issue the notes in tranches of €500,000 each, with each tranche comprising 500 convertible notes in the form of bearer bonds each with a nominal value of €1,000. The bonds are transferable only with approval by Epigenomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.